C3aR deficiency in mice had a major impact on T-cell-dependent antitumor effector mechanisms, and the frequency of tumor-infiltrating CD4+ T lymphocytes was significantly increased in C3aR-deficient mice to mediate a more robust adaptive immune response against cancer [32]. Here, CD4 is linked to neoplasm.